You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
BioNTech及辉瑞指其疫苗对预防南非变种病毒有效
阿思达克 04-07 15:59
BioNTech(BNTX.US)及辉瑞(PFE.US)公布,确认其新型肺炎病毒疫苗在接种第二剂六个月後仍具高效性且没有严重安全隐患,其临床试验数据表明其新型肺炎疫苗对预防最初在南非发现而更具传染性的B.1.351变种病毒有效。公布指,在南非800名参与者的研究中,该疫苗对预防包括B.1351变种病毒在内的新型肺炎功效达100%。

公告引述研究指,在通过对受试者在二次接种後第七天起至长达六个月的随访中,BNT162B2仍具有高达91.3%的有效性。BioNTech联合创始人兼行政总裁Ugur Sahin表示,数据提供初步的临床结果,表明疫苗可有效预防目前流行的病毒变异,为实现群体免疫和终结新冠疫情的关键因素。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account